ShK-186: Phase Ib complete enrollment

Kineta completed enrollment in a double-blind, placebo-controlled, Canadian Phase

Read the full 96 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE